3I Group Plc:企業の戦略・SWOT・財務分析

◆英語タイトル:3I Group Plc - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY3334
◆発行会社(調査会社):MarketLine
◆発行日:2019年11月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:Financial Services
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

3I Group Plc – Strategy, SWOT and Corporate Finance Report
Summary

3I Group Plc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

3i Group Plc (3i) is an investment company with two complementary businesses, infrastructure and private equity, which specializes in core investment markets of Europe and North America. Infrastructure involves in asset management and investment to generate cash income and capital returns; and administers three European infrastructure funds and one India infrastructure fund. It acts as an investment adviser to 3i Infrastructure Plc that concentrates on greenfield project investments and economic infrastructure in the developed economies. Private equity invests in mid-market companies, which have enterprise value between GBP100 million to GBP500 million taking a major stake. Its new investments are majorly concentrated on North America and Northern Europe. 3i is headquartered in London, the UK.

Scope

- Detailed information on 3I Group Plc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting 3I Group Plc in the form of a SWOT analysis
- An in-depth view of the business model of 3I Group Plc including a breakdown and examination of key business segments
- Intelligence on 3I Group Plc’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about 3I Group Plc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of 3I Group Plc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess 3I Group Plc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on 3I Group Plc’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
3i Group Plc: Company Overview
3i Group Plc: Overview and Key Facts
3i Group Plc: Overview
3i Group Plc: Key Facts
3i Group Plc: Key Employees
3i Group Plc: Key Employee Biographies
3i Group Plc: Major Products and Services
3i Group Plc: Company History
3i Group Plc: Management Statement
3i Group Plc: Locations and Subsidiaries
3i Group Plc: Key Competitors
3i Group Plc: Company Analysis
3i Group Plc: Business Description
3i Group Plc: SWOT Analysis
3i Group Plc: SWOT Overview
3i Group Plc: Strengths
3i Group Plc: Weaknesses
3i Group Plc: Opportunities
3i Group Plc: Threats
3i Group Plc: Corporate Financial Deals Activity
3i Group Plc: Financial Deals Overview
3i Group Plc: Targets and Partners
3i Group Plc: Top Deals 2015 – 2019YTD*
3i Group Plc: Advisors
3i Group Plc: Top Legal Advisors
3i Group Plc: Top Financial Advisors
3i Group Plc: Mergers and Acquisitions
3i Group Plc: Divestments
3i Group Plc: Recent Developments
3i Group Plc: News and Events Summary
3i Group Plc: Contracts
3i Group Plc: Corporate Governance
3i Group Plc: Financial Deals
3i Group Plc: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: 3i Group Plc: Key Facts
Table 2: 3i Group Plc: Key Employees
Table 3: 3i Group Plc: Company History
Table 4: 3i Group Plc: Locations and Subsidiaries
Table 5: 3i Group Plc: Key Competitors
Table 6: 3i Group Plc: Deal Activity by Deal Type - Volume (TTM*)
Table 7: 3i Group Plc: M&A Activity by Geography (TTM*)
Table 8: 3i Group Plc: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 9: 3i Group Plc: M&A Average Deal Size - Value (US$m)
Table 10: 3i Group Plc: Targets and Partners
Table 11: 3i Group Plc: Top Deals 2015 - 2019YTD*
Table 12: 3i Group Plc: Legal Advisor Ranking by Value (US$m)
Table 13: 3i Group Plc: Financial Advisor Ranking by Value (US$m)
Table 14: 3i Group Plc: M&A Volume and Value Trend (2015 - YTD*2019)
Table 15: 3i Group Plc: M&A Activity by Geography (2015 - YTD*2019)
Table 16: 3i Group Plc: Divestments Volume and Value Trend (2015 - YTD*2019)
Table 17: 3i Group Plc: Divestments by Geography (2015 - YTD*2019)
Table 18: 3i Group Plc: News and Events Summary
Table 19: 3i Group Plc: Contracts
Table 20: 3i Group Plc: Corporate Governance
Table 21: 3i Group Plc: Financial Deals
Table 22: 3i Group Plc: Strategy and Operations

★海外企業調査レポート[3I Group Plc:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cimab SA-製薬・医療分野:企業M&A・提携分析
    Summary Cimab SA (Cimab) is a biopharmaceutical company that develops and markets monoclonal antibodies and other recombinant proteins for the diagnosis and treatment of cancer and other diseases related to the immune system. The company offers products such as cimaher nimotuzumab, ior epocim epoeti …
  • Warpaint London plc (W7L):企業の財務・戦略的SWOT分析
    Warpaint London plc (W7L) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Clean Energy Fuels Corp (CLNE):石油・ガス:M&Aディール及び事業提携情報
    Summary Clean Energy Fuels Corp (Clean Energy) is an oil and gas company that offers natural gas fuel transportation services. The company’s products fuels, liquefied natural gas, compressed natural gas, renewable natural gas, and bulk fuels. It also provides storage systems, compressors, dispensers …
  • Inovalon Holdings Inc (INOV):企業の財務・戦略的SWOT分析
    Summary Inovalon Holdings Inc (Inovalon), is a technology company that provides cloud-based platforms for healthcare industry. The company designs, develops and distributes software tools to provide healthcare and financial improvement solutions. It offers Inovalon ONE platform and provides data dri …
  • Nanyang Technological University:企業の戦略的SWOT分析
    Nanyang Technological University - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • M. A. Mortenson Company:企業の戦略・SWOT・財務情報
    M. A. Mortenson Company - Strategy, SWOT and Corporate Finance Report Summary M. A. Mortenson Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Specialised Therapeutics Australia Pty Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Specialised Therapeutics Australia Pty Ltd (STA) is a biopharmaceutical company that develops and commercializes therapies and technologies for unmet medical needs. The company’s product portfolio includes abraxane, gliolan, oncotype dx, iclusig, oncotype dx prostate and aloxi. Its pipeline …
  • Anheuser-Busch Companies LLC:企業の戦略的SWOT分析
    Anheuser-Busch Companies LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Papeles y Cartones de Europa SA:企業の戦略・SWOT・財務情報
    Papeles y Cartones de Europa SA - Strategy, SWOT and Corporate Finance Report Summary Papeles y Cartones de Europa SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Revolution Medicines Inc-製薬・医療分野:企業M&A・提携分析
    Summary Revolution Medicines Inc (Revolution Medicines) is a drug discovery company with focus on the development of therapies for cancer. The company’s programs include SHP2 Program and mTOR Program. Its REVBLOCKS platform, an integrated suite of modular synthesis methodologies, facilitates the pro …
  • Aldi Einkauf GmbH & Co oHG:企業の戦略・SWOT・財務情報
    Aldi Einkauf GmbH & Co oHG - Strategy, SWOT and Corporate Finance Report Summary Aldi Einkauf GmbH & Co oHG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Ws Atkins Ltd
    Ws Atkins Ltd - Strategy, SWOT and Corporate Finance Report Summary Ws Atkins Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Andrade Gutierrez SA:企業の戦略的SWOT分析
    Andrade Gutierrez SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • New Carolin Gold Corp:企業の戦略・SWOT・財務情報
    New Carolin Gold Corp - Strategy, SWOT and Corporate Finance Report Summary New Carolin Gold Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • FirstGroup plc (FGP):企業の財務・戦略的SWOT分析
    FirstGroup plc (FGP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Merck & Co Inc (MRK):企業の財務・戦略的SWOT分析
    Merck & Co Inc (MRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Martinrea International Inc.:戦略・SWOT・企業財務分析
    Martinrea International Inc. - Strategy, SWOT and Corporate Finance Report Summary Martinrea International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • University of California San Diego:医療機器:M&Aディール及び事業提携情報
    Summary University of California San Diego (UCSD), a subsidiary of University of California, is a public research university that offers education and research with a portfolio of undergraduate, graduate, postdoctoral and professional schools. It offers courses in various fields including arts and h …
  • Royal Mail plc:企業の戦略・SWOT・財務情報
    Royal Mail plc - Strategy, SWOT and Corporate Finance Report Summary Royal Mail plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Humabs BioMed SA-製薬・医療分野:企業M&A・提携分析
    Summary Humabs BioMed SA (Humabs) is an antibody therapeutics biotechnology company that discovers and develops human monoclonal antibodies. The company’s pipeline programs include Flu A virus, ebola virus, HBV, rabies virus, JCV, dengue, and others. It develops cellclone technologies, a proprietary …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆